Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25024388
DOI
10.4049/jimmunol.1302974
PII: jimmunol.1302974
Knihovny.cz E-resources
- MeSH
- Adaptor Proteins, Vesicular Transport immunology MeSH
- Adenylate Cyclase Toxin immunology MeSH
- CD11b Antigen immunology MeSH
- B7-1 Antigen biosynthesis MeSH
- B7-2 Antigen biosynthesis MeSH
- Bordetella pertussis immunology MeSH
- Cell Differentiation immunology MeSH
- T-Lymphocytes, Cytotoxic immunology MeSH
- Dendritic Cells cytology immunology MeSH
- Interferon-beta immunology MeSH
- Interleukin-1beta biosynthesis MeSH
- Interleukin-6 biosynthesis MeSH
- Cells, Cultured MeSH
- Mice, Inbred C57BL MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Receptor, Interferon alpha-beta genetics MeSH
- Receptors, Interleukin-1 immunology MeSH
- Signal Transduction immunology MeSH
- Tumor Necrosis Factor-alpha biosynthesis MeSH
- Toll-Like Receptor 4 immunology MeSH
- Tyrosine genetics MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adaptor Proteins, Vesicular Transport MeSH
- Adenylate Cyclase Toxin MeSH
- CD11b Antigen MeSH
- B7-1 Antigen MeSH
- B7-2 Antigen MeSH
- Cd86 protein, mouse MeSH Browser
- Interferon-beta MeSH
- Interleukin-1beta MeSH
- Interleukin-6 MeSH
- Receptor, Interferon alpha-beta MeSH
- Receptors, Interleukin-1 MeSH
- TICAM-1 protein, mouse MeSH Browser
- Tlr4 protein, mouse MeSH Browser
- Tumor Necrosis Factor-alpha MeSH
- Toll-Like Receptor 4 MeSH
- Tyrosine MeSH
Deciphering the mechanisms that allow the induction of strong immune responses is crucial to developing efficient vaccines against infectious diseases and cancer. Based on the discovery that the adenylate cyclase from Bordetella pertussis binds to the CD11b/CD18 integrin, we developed a highly efficient detoxified adenylate cyclase-based vector (CyaA) capable of delivering a large variety of Ags to the APC. This vector allows the induction of protective and therapeutic immunity against viral and tumoral challenges as well as against transplanted tumors in the absence of any added adjuvant. Two therapeutic vaccine candidates against human papilloma viruses and melanoma have been developed recently, based on the CyaA vector, and are currently in clinical trials. We took advantage of one of these highly purified vaccines, produced under good manufacturing practice-like conditions, to decipher the mechanisms by which CyaA induces immune responses. In this study, we demonstrate that CyaA binds both human and mouse CD11b(+) dendritic cells (DCs) and induces their maturation, as shown by the upregulation of costimulatory and MHC molecules and the production of proinflammatory cytokines. Importantly, we show that DCs sense CyaA through the TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β pathway, independent of the presence of LPS. These findings show that CyaA possesses the intrinsic ability to not only target DCs but also to activate them, leading to the induction of strong immune responses. Overall, this study demonstrates that Ag delivery to CD11b(+) DCs in association with TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β activation is an efficient strategy to promote strong specific CD8(+) T cell responses.
References provided by Crossref.org
Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells